Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Background: Early diagnosis of dementia can significantly improve care planning and patient outcomes while delaying progression. Machine learning algorithms can identify patterns in clinical and neuroimaging data that may aid in the early detection of dementia risk factors. Objective: To evaluate the performance of the ensemble machine learning pipeline for classifying dementia status utilizing de...
Objective Accurate and scalable disease phenotyping from electronic health records (EHRs) is foundational for predictive modeling and precision medicine. Traditional rule- and keyword-based approaches are limited by inconsistent documentation and inability to capture clinical nuance. We aim to evaluate whether large language models (LLMs) can overcome these limitations to improve dementia phenotyp...
The spatiotemporal progression of tau aggregates in neurodegenerative diseases like Alzheimer's follows the brain's structural connectome, yet a profo...
Discovery of sensitive and biologically grounded biomarkers is essential for early detection and monitoring of Alzheimer's disease (AD). Structural MR...
Early and accurate diagnosis of Alzheimer's Disease (AD) is critical for effective intervention. While previous studies have explored speech-based bio...
Accurately modeling longitudinal brain MRI progression is crucial for understanding neurodegenerative diseases and predicting individualized structura...
Early and accurate classification of Alzheimers disease (AD) from brain MRI scans is essential for timely clinical intervention and improved patient o...
Digital pathology using whole slide imaging (WSI) and artificial intelligence (AI) has the potential to transform diagnostic workflows, but adoption r...
Early detection of neurodegenerative diseases such as Alzheimer's Disease (AD) and Frontotemporal Dementia (FTD) is essential for reducing the risk of...
Estimating brain age (BA) from T1-weighted magnetic resonance images (MRIs) provides a useful approach to map the anatomic features of brain senescenc...
Parkinson's disease (PD) and Alzheimer's disease (AD) are the two most prevalent and incurable neurodegenerative diseases (NDs) worldwide, for which e...
Aging is often accompanied by cognitive decline, but the extent, timing, and severity of this process is subject to large inter-individual variability...
BackgroundThe ATN (Amyloid/Tau/Neurodegeneration) framework provides a theory-driven approach to Alzheimers disease (AD) classification using binary b...
Aging, the leading risk factor for numerous diseases, manifests through diverse structural and architectural changes in human tissues, providing an op...
The study of neuronal activity is essential for understanding brain function and its alterations in neurodegenerative diseases. Advances in in vivo im...
The unknown pathogenic mechanisms of Alzheimer's disease (AD) make treatment challenging. Neuroimaging genetics offers a method for identifying diseas...
Objective While Alzheimer's disease (AD) and frontotemporal dementia (FTD) show some common memory deficits, these two disorders show partially over...
We introduce scenario-based cognitive status identification in older drivers from Naturalistic driving videos and large vision models. In recent tim...
Alzheimer's disease (AD) is a neurodegenerative disorder that affects millions worldwide. In the absence of effective treatment options, early diagn...
Alzheimer's disease (AD) is a neurodegenerative disorder with no known cure that affects tens of millions of people worldwide. Early detection of AD...